| Dr Shao-i Huang, DO | |
|
27200 Calaroga Ave, Hayward, CA 94545-4339 | |
| (510) 264-4000 | |
| Not Available |
| Full Name | Dr Shao-i Huang |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 27200 Calaroga Ave, Hayward, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215031455 | NPI | - | NPPES |
| 00AX90570 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A9057 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| John Muir Medical Center - Concord Campus | Concord, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
A close cousin of the bacterium that debilitated thousands of World War I soldiers has been isolated at UCSF from a patient who had been on an international vacation.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
The Prostate Conditions Education Council, a national organization committed to men's health and a leader in prostate cancer early detection, released the following statement in response to new clinical practice guideline released today by the American Urological Association.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
A close cousin of the bacterium that debilitated thousands of World War I soldiers has been isolated at UCSF from a patient who had been on an international vacation.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
The Prostate Conditions Education Council, a national organization committed to men's health and a leader in prostate cancer early detection, released the following statement in response to new clinical practice guideline released today by the American Urological Association.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shao-i Huang, DO 2100 Powell St, Suite 900, Emeryville, CA 94608-1826 Ph: (510) 350-2600 | Dr Shao-i Huang, DO 27200 Calaroga Ave, Hayward, CA 94545-4339 Ph: (510) 264-4000 |
News Archive
A close cousin of the bacterium that debilitated thousands of World War I soldiers has been isolated at UCSF from a patient who had been on an international vacation.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
The Prostate Conditions Education Council, a national organization committed to men's health and a leader in prostate cancer early detection, released the following statement in response to new clinical practice guideline released today by the American Urological Association.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
› Verified 2 days ago
Dr. Aaron Pessl, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 27400 Hesperian Blvd, Hayward, CA 94545 Phone: 510-784-4525 | |
Rameshchandra Naranbhai Patel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 27400 Hesperian Blvd, Hayward, CA 94545 Phone: 510-784-4000 | |
Sarah Lynn Welsh, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 27200 Calaroga Ave, Hayward, CA 94545 Phone: 510-264-4026 | |
Dr. Christopher Wan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 27400 Hesperian Blvd, Kaiser Hayward Emergency Dept., Hayward, CA 94545 Phone: 510-784-4521 | |
Charles Getz, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 27400 Hesperian Blvd, Hayward, CA 94545 Phone: 510-784-4000 | |
Eric Anderson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 27400 Hesperian Blvd, Hayward, CA 94545 Phone: 510-784-4000 |